Pure Global

Multi-center retrospective study on efficacy and safety of new-generation microwave ablation in patients with hepatocellular carcinoma - Trial UMIN000052612

Access comprehensive clinical trial information for UMIN000052612 through Pure Global AI's free database. This phase not specified trial is sponsored by Keio University and is currently Not yet recruiting. The study focuses on Hepatocellular carcinoma.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000052612
Not yet recruiting
Trial Details
University Hospital Medical Information Network โ€ข UMIN000052612
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Multi-center retrospective study on efficacy and safety of new-generation microwave ablation in patients with hepatocellular carcinoma

Study Focus

Hepatocellular carcinoma

Observational

Sponsor & Location

Keio University

Japan

Timeline & Enrollment

N/A

Oct 26, 2023

N/A

ICD-10 Classifications

Malignant neoplasm: Hepatoblastoma
Malignant neoplasm: Liver cell carcinoma
Malignant neoplasm: Other specified carcinomas of liver
Malignant neoplasm: Liver, unspecified
Malignant neoplasm: Hepatic flexure

Data Source

University Hospital Medical Information Network

UMIN000052612

Non-Device Trial